"Antineoplastic Protocols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clinical protocols used to inhibit the growth or spread of NEOPLASMS.
| Descriptor ID |
D024221
|
| MeSH Number(s) |
E02.183.750 E02.319.077 N05.715.360.775.225.500
|
| Concept/Terms |
Antineoplastic Protocols- Antineoplastic Protocols
- Antineoplastic Protocol
- Protocol, Antineoplastic
- Protocols, Antineoplastic
- Cancer Treatment Protocols
- Cancer Treatment Protocol
- Protocol, Cancer Treatment
- Protocols, Cancer Treatment
- Treatment Protocol, Cancer
- Treatment Protocols, Cancer
|
Below are MeSH descriptors whose meaning is more general than "Antineoplastic Protocols".
Below are MeSH descriptors whose meaning is more specific than "Antineoplastic Protocols".
This graph shows the total number of publications written about "Antineoplastic Protocols" by people in this website by year, and whether "Antineoplastic Protocols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antineoplastic Protocols" by people in Profiles.
-
Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment. Obstet Gynecol. 2021 01 01; 137(1):108-121.
-
Disparities in survival after trimodality therapy for esophageal adenocarcinoma. Dis Esophagus. 2018 Sep 01; 31(9).
-
Phase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial Efficiency. J Pediatr Hematol Oncol. 2016 07; 38(5):360-6.
-
Conventional dosing of anticancer agents: precisely wrong or just inaccurate? Clin Pharmacol Ther. 2014 Apr; 95(4):361-4.
-
The impact of ex vivo clinical grade activation protocols on human T-cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapy. J Immunother. 2010 Oct; 33(8):759-68.
-
Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral Oncol. 2007 Mar; 43(3):289-300.
-
Autologous and allogeneic transplantation for aggressive NHL. Cytotherapy. 2002; 4(3):223-40.